Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Teva

I walked for miles to find the best summer hiking boots for women — these ones made the cut

From trail to town, step out in supportive, stylish and breathable hiking boots this summer. Sian Lewis lays out the best

Evening Standard

Stacey Dooley’s chunky slingback sandals are the versatile everyday shoe we’re relying on for warmer weather

Chic and comfortable - what's not to love?

Woman & Home

The Saturday Spread: Letting the Smart Money Act as an Early Warning Sign

Since the most sophisticated market participants have access to resources that regular folks lack, their posture can clue us into potential sentiment swings.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

This International Pharma Stock Just Hit 5-Year Highs

Teva Pharmaceutical (TEVA) is trading at new 5-year highs. Shares are up more than 40% over the past year. The stock has strong technical momentum, maintaining a 100% “Buy” opinion from Barchart. TEVA offers international diversification and is favored by both Wall Street and individual investors. Today’s Featured Stock Valued...

Barchart

FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines.

The Conversation

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points on Wednesday.

Benzinga

Drugmakers Recall Blood Pressure Pills Contaminated with Cancer-Causing Chemical, FDA Says

Teva Pharmaceuticals has recalled over 580,000 bottles of prazosin hydrochloride, a common blood pressure and PTSD medication, after tests detected a nitrosamine impurity, which the FDA warns may cause cancer with long-term exposure.

International Business Times UK

Read news from The Economist, FT, and more,
with one subscription

Widely used blood pressure medication recalled over ‘cancer-causing’ chemicals

Pharmaceutical company says it has not yet received any ‘relevant complaints’ related to the recalled medication

The Independent UK

Blood Pressure Medication Recalled Because Of Cancer Risk: What Is Prazosin Hydrochloride

Teva Pharmaceuticals orders a nationwide recall of their Prazosin Hydrochloride capsules.

International Business Times UK

Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs

The Trump administration is reportedly planning to exclude imported generic drugs from tariffs.

Benzinga

Helen Skelton knows how to dress for warm but windy weather in wide-leg jeans and a chic wax jacket

Helen’s fail-safe autumn outfit formula makes dressing for tricky transitional weather a breeze

Woman & Home

Struggling to style long denim shorts? Helen Skelton pulls them off effortlessly with her striped blouse and chunky sandals

As we cling to the warm summer weather, denim shorts are a staple – and Helen’s effortlessly casual styling is perfect inspiration

Woman & Home

Teva Launches Generic GLP-1 Weight Loss Drug With FDA Nod For Saxenda

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major players to seek FDA approvals for generic versions of popular medications, reshaping the competitive landscape and providing more choices for consumers.

Benzinga

Teva Aventrail Running Sandals review: these maximalist open-toe trail shoes are a bit of a plot twist

Cushioned to the max, these trail-running sandals are comfortable underfoot and surprisingly capable on straightforward trails

Advnture

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Teva Pharma Boosts Outlook For Key Innovative Drugs Austedo, Ajovy, Uzedy

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy.

Benzinga

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will release its second-quarter 2025 financial results tomorrow, July 30.

Evening Standard

Chic, ultra-curated and small-batch: how second-hand fashion is moving on from Vinted

Style-conscious shoppers are increasingly turning to small-batch fashion sites to curate their look for them. As second-hand September kicks off, we meet the people making it happen

Barchart

Teva Pharmaceutical (TEVA) Just Flashed a Statistically Viable Signal for Bullish Traders

Using principles from applied game theory, options traders may have an intriguing opportunity with TEVA stock.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

While you may be attached to strappy sandals – here are some trending options that won’t leave you with blisters.

Woman & Home

Victoria Beckham swears by this flattering jeans shape, and her tomato red polo top makes them feel so fresh for 2025

She was pictured in Paris, wearing the denim style she's championed for over a decade

Woman & Home

It's true: it doesn't get any chicer than Demi Moore's white turn-up jeans and comfy Teva sandals

We've found similar Tevas for under £30

Marie Claire

According to Mary-Kate Olsen, these Affordable Sandals are the Only Style you Need this Summer

And no, they're not from The Row

Sandals on the trail: smart swap or risky move?

Hiking sandals are making a comeback as an outdoor staple, but are they really adventure-ready?

The Guardian - UK

EU drug companies warn of exodus to US as Trump threatens import tariffs

Von der Leyen urged to take ‘rapid and radical action’ as president says tariffs on pharmaceuticals coming ‘shortly’

Barchart

These Are the 2 Worst-Performing S&P 500 Stocks in 2025. Should You Buy the Dip?

This article highlights the two worst-performing S&P 500 stocks in 2025 and discusses whether they present a buying opportunity.

1 2 3 4 5

People

Deborah SheridanTaylor

16 stories

Lady Victoria

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.